Clinical Trials · NCT06598839
Immuno-effect of Tα1 for Stage I NSCLC
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Yousheng Mao
- Enrollment
- 40
- Start date
- Jun 2024
- Locations
- 1 site, China
- Primary endpoint
- Number of CTCs
Search for a command to run...